Eva Esteban‐Cardeñosa

469 total citations
13 papers, 320 citations indexed

About

Eva Esteban‐Cardeñosa is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Eva Esteban‐Cardeñosa has authored 13 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 10 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Eva Esteban‐Cardeñosa's work include BRCA gene mutations in cancer (11 papers), CRISPR and Genetic Engineering (5 papers) and Cancer Genomics and Diagnostics (4 papers). Eva Esteban‐Cardeñosa is often cited by papers focused on BRCA gene mutations in cancer (11 papers), CRISPR and Genetic Engineering (5 papers) and Cancer Genomics and Diagnostics (4 papers). Eva Esteban‐Cardeñosa collaborates with scholars based in Spain, Montenegro and Belgium. Eva Esteban‐Cardeñosa's co-authors include Mar Infante, M. Durán, Cristina Miner, Eladio A. Velasco, David J. Sanz, Lucía Pérez‐Cabornero, Alberto Acedo, Miguel de la Hoya, Orland Dı́ez and Ana Osório and has published in prestigious journals such as Clinical Cancer Research, Nature Protocols and International Journal of Cancer.

In The Last Decade

Eva Esteban‐Cardeñosa

13 papers receiving 315 citations

Peers

Countries citing papers authored by Eva Esteban‐Cardeñosa

Since Specialization

Citations

This map shows the geographic impact of Eva Esteban‐Cardeñosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Esteban‐Cardeñosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Esteban‐Cardeñosa more than expected).

Fields of papers citing papers by Eva Esteban‐Cardeñosa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Esteban‐Cardeñosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Esteban‐Cardeñosa. The network helps show where Eva Esteban‐Cardeñosa may publish in the future.

Co-authorship network of co-authors of Eva Esteban‐Cardeñosa

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Esteban‐Cardeñosa. A scholar is included among the top collaborators of Eva Esteban‐Cardeñosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Esteban‐Cardeñosa. Eva Esteban‐Cardeñosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Germline Genetic Findings Which May Impact Therapeutic Decisions in Families with a Presumed Predisposition for Hereditary Breast and Ovarian Cancer 2020 ·Cancers ·Carolina Velázquez, Kim De Leeneer, Eva Esteban‐Cardeñosa, Francisco Avila Cobos, (unknown), (unknown), (unknown), Carmen D. Lobatón, Kathleen Claes, M. Durán, Mar Infante	6
2	A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer 2018 ·The Breast ·Carolina Velázquez, Eva Esteban‐Cardeñosa, (unknown), (unknown), (unknown), Carmen D. Lobatón, M. Durán, Mar Infante	7
3	Unraveling the molecular effect of a rare missense mutation in BRIP1 associated with inherited breast cancer 2018 ·Molecular Carcinogenesis ·Carolina Velázquez, Eva Esteban‐Cardeñosa, (unknown), (unknown), (unknown), Carmen D. Lobatón, M. Durán, Mar Infante	4
4	The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins 2013 ·Carcinogenesis ·Mar Infante, M. Durán, Alberto Acedo, (unknown), (unknown), A. Barroso, Miguel A. García-González, Lídia Feliubadaló, Adriana Lasa, Miguel de la Hoya, Eva Esteban‐Cardeñosa, Orland Dı́ez, Cristina Martínez-Bouzas, (unknown), Àlex Teulé, Ana Osório, (unknown), Rogelio González‐Sarmiento, Cristina Miner, Eladio A. Velasco	14
5	A High Proportion of DNA Variants of BRCA1 and BRCA2 Is Associated with Aberrant Splicing in Breast/Ovarian Cancer Patients 2010 ·Clinical Cancer Research ·David J. Sanz, Alberto Acedo, Mar Infante, M. Durán, Lucía Pérez‐Cabornero, Eva Esteban‐Cardeñosa, (unknown), (unknown), Cristina Miner, Eladio A. Velasco	84
6	Two founder BRCA2 mutations predispose to breast cancer in young women 2009 ·Breast Cancer Research and Treatment ·Mar Infante, M. Durán, Adriana Lasa, Alberto Acedo, Miguel de la Hoya, Eva Esteban‐Cardeñosa, David J. Sanz, Lucía Pérez‐Cabornero, (unknown), Cristina Miner, Eladio A. Velasco	8
7	BRCA1 5272‐1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin 2009 ·Clinical Genetics ·Mar Infante, M. Durán, Alberto Acedo, Lucía Pérez‐Cabornero, David J. Sanz, Miguel A. García-González, Elena Beristain, Eva Esteban‐Cardeñosa, Miguel de la Hoya, Àlex Teulé, Ana Vega, María‐Isabel Tejada, (unknown), Cristina Miner, (unknown)	13
8	Heteroduplex analysis by capillary array electrophoresis for rapid mutation detection in large multiexon genes 2007 ·Nature Protocols ·Eladio A. Velasco, Mar Infante, M. Durán, Lucía Pérez‐Cabornero, David J. Sanz, Eva Esteban‐Cardeñosa, Cristina Miner	37
9	High proportion of novel mutations of BRCA1 and BRCA2 in breast/ovarian cancer patients from Castilla-León (central Spain) 2006 ·Journal of Human Genetics ·Mar Infante, M. Durán, Eva Esteban‐Cardeñosa, Cristina Miner, Eladio A. Velasco	30
10	Rapid mutation detection in complex genes by heteroduplex analysis with capillary array electrophoresis 2005 ·Electrophoresis ·Eladio A. Velasco, Mar Infante, M. Durán, Eva Esteban‐Cardeñosa, (unknown), Carlos García Girón, Cristina Miner	19
11	High-Throughput Mutation Detection Method to Scan BRCA1 and BRCA2 Based on Heteroduplex Analysis by Capillary Array Electrophoresis 2004 ·Clinical Chemistry ·Eva Esteban‐Cardeñosa, M. Durán, Mar Infante, Eladio A. Velasco, Cristina Miner	20
12	Mutational analysis ofBRCA2in Spanish breast cancer patients from Castilla-Leon: Identification of four novel truncating mutations 2003 ·Human Mutation ·M. Durán, Eva Esteban‐Cardeñosa, Eladio A. Velasco, Mar Infante, Cristina Miner	19
13	The breast cancer low‐penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population 2003 ·International Journal of Cancer ·Ana Osório, Raquel Rodríguez‐López, Orland Dı́ez, Miguel de la Hoya, José I. Martínez, Ana Vega, Eva Esteban‐Cardeñosa, Carmen Alonso, Trinidad Caldés, Javier Benı́tez	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact